200 related articles for article (PubMed ID: 6801078)
1. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency.
Imperato-McGinley J; Peterson RE; Gautier T; Cooper G; Danner R; Arthur A; Morris PL; Sweeney WJ; Shackleton C
J Clin Endocrinol Metab; 1982 May; 54(5):931-41. PubMed ID: 6801078
[No Abstract] [Full Text] [Related]
2. Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers.
Imperato-McGinley J; Peterson RE; Gautier T; Arthur A; Shackleton C
J Clin Endocrinol Metab; 1985 Mar; 60(3):553-8. PubMed ID: 3972966
[TBL] [Abstract][Full Text] [Related]
3. Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization.
Kuttenn F; Mowszowicz I; Wright F; Baudot N; Jaffiol C; Robin M; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1979 Dec; 49(6):861-5. PubMed ID: 511977
[No Abstract] [Full Text] [Related]
4. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism.
Imperato-McGinley J; Guerrero L; Gautier T; Peterson RE
Science; 1974 Dec; 186(4170):1213-5. PubMed ID: 4432067
[TBL] [Abstract][Full Text] [Related]
5. 5 alpha-reductase deficiency in humans: support to the theory that 5 alpha-reduction of testosterone is an essential step in the control of LH secretion.
Martini L; Celotti F; Serio M
J Endocrinol Invest; 1979; 2(4):463-4. PubMed ID: 536582
[No Abstract] [Full Text] [Related]
6. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
[TBL] [Abstract][Full Text] [Related]
7. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
[TBL] [Abstract][Full Text] [Related]
8. Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency.
Peterson RE; Imperato-McGinley J; Gautier T; Sturla E
Am J Med; 1977 Feb; 62(2):170-91. PubMed ID: 835597
[TBL] [Abstract][Full Text] [Related]
9. The coexistence of male pseudohermaphrodites with 17-ketosteroid reductase deficiency and 5 alpha-reductase deficiency within a Turkish kindred.
Imperato-McGinley J; Akgun S; Ertel NH; Sayli B; Shackleton C
Clin Endocrinol (Oxf); 1987 Jul; 27(1):135-43. PubMed ID: 3477349
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of human chorionic gonadotropins (HCG) stimulation test in XY-disorders of sex development (XY-DSD) presented in Armed Forces Institute of Pathology.
Sheikh WH; Asif N; Haroon ZH; Ejaz A; Ain QU; Shehzad N
J Pak Med Assoc; 2019 Aug; 69(8):1090-1093. PubMed ID: 31431758
[TBL] [Abstract][Full Text] [Related]
11. 5 alpha-reductase deficiency: diagnosis via abnormal plasma levels of reduced testosterone derivatives.
Corrall RJ; Wakelin K; O'Hare JP; O'Brien IA; Ishmail AA; Honour J
Acta Endocrinol (Copenh); 1984 Dec; 107(4):538-43. PubMed ID: 6516699
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and clinical effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
Szilágyi A; Homoki J; Bellyei S; Szabó I
Gynecol Endocrinol; 2000 Oct; 14(5):337-41. PubMed ID: 11109973
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis of 5 alpha-reductase deficiency in infancy.
Imperato-McGinley J; Gautier T; Pichardo M; Shackleton C
J Clin Endocrinol Metab; 1986 Dec; 63(6):1313-8. PubMed ID: 3782419
[TBL] [Abstract][Full Text] [Related]
15. Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity.
Imperato-McGinley J; Peterson RE; Gautier T; Sturla E
J Steroid Biochem; 1979 Jul; 11(1B):637-45. PubMed ID: 491628
[No Abstract] [Full Text] [Related]
16. Clinical, endocrinological, and enzymatic characterization of two patients with 5 alpha-reductase deficiency: evidence that a single enzyme is responsible for the 5 alpha-reduction of cortisol and testosterone.
Fisher LK; Kogut MD; Moore RJ; Goebelsmann U; Weitzman JJ; Isaacs H; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1978 Sep; 47(3):653-64. PubMed ID: 263318
[TBL] [Abstract][Full Text] [Related]
17. Steroid 5 alpha-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity.
Imperato-McGinley J; Peterson RE; Leshin M; Griffin JE; Cooper G; Draghi S; Berenyi M; Wilson JD
J Clin Endocrinol Metab; 1980 Jan; 50(1):15-22. PubMed ID: 7350177
[TBL] [Abstract][Full Text] [Related]
18. Post-pubertal female psychosexual orientation in incomplete male pseudohermaphroditism type 2 (5 alpha-reductase deficiency).
Cantú JM; Corona-Rivera E; Díaz M; Medina C; Esquinca E; Cortés-Gallegos V; Vaca G; Hernández A
Acta Endocrinol (Copenh); 1980 Jun; 94(2):273-9. PubMed ID: 6774548
[TBL] [Abstract][Full Text] [Related]
19. Different aspects of 5 alpha-reductase deficiency in male pseudohermaphroditism and hypothyroidism.
Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Wright F
Clin Endocrinol (Oxf); 1981 May; 14(5):459-69. PubMed ID: 7307277
[No Abstract] [Full Text] [Related]
20. Male pseudohermaphroditism with 5-alpha-reductase deficiency: report of two new familial cases. The importance of early diagnosis.
Aguilar-Diosdado M; Gavilán-Villarejo I; Escobar-Jiménez L; Beltrán J; Girón JA
J Pediatr Endocrinol Metab; 1995; 8(1):67-71. PubMed ID: 7584701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
